Pharmaxis Ltd (PMXSF)
OTC
Healthcare
Drug Manufacturers - Specialty & Generic
$0.03
▲ +0.00%
Market Cap
$31.0M
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Beta
0.27
52-Wk Range
0.026-0.026
CEO
Gary Jonathan Phillips
Country
AU
Currency
USD
Pharmaxis Ltd, an Australian biopharmaceutical company established in 1998 and headquartered in Frenchs Forest, specializes in the global research, development, and commercialization of therapeutic products for fibrotic and inflammatory diseases. Its business is organized into two main divisions: the Mannitol Respiratory Business and New Drug Development. The company currently markets Bronchitol, an inhaled dry powder medication for the treatment of cystic fibrosis, and Aridol, a diagnostic tool used to detect hyper-responsive airways and assist in the diagnosis and management of asthma. Pharm…
Open full interactive analysis & DCF →